Close

We use cookies to improve your experience of our website. Privacy Policy

Skip to main content
Menu

Prof Lou Metherell

Lou Metherell

Professor of Endocrine Genetics

Centre for Endocrinology, William Harvey Research Institute
School of Medicine & Dentistry, Queen Mary University of London

www.qmul.ac.uk/whri/people/academic-staff/items/metherelllou.html

Publications of specific relevance to Predictive in vitro Models

Publications

2020

Maharaj A, Theodorou D, Banerjee I, Metherell LA, Prasad R and Wallace D (2020). A Sphingosine-1-Phosphate Lyase Mutation Associated With Congenital Nephrotic Syndrome and Multiple Endocrinopathy. Frontiers in Pediatrics  vol. 8, 10.3389/fped.2020.00151
Williams JL, Paudyal A, Awad S, Nicholson J, Grzesik D, Botta J, Meimaridou E, Maharaj AV, Stewart M, Tinker A, Cox RD and Metherell LA (2020). Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do not. Life Science Alliance  vol. 3, (4) 10.26508/lsa.201900593
Kallali W, Gray E, Mehdi MZ, Lindsay R, Metherell LA, Buonocore F, Suntharalingham JP, Achermann JC and Donaldson M (2020). Long-term outcome of partial P450 side-chain cleavage enzyme deficiency in three brothers: The importance of early diagnosis. Bioscientifica  European Journal of Endocrinology  vol. 182, (3) K15-K24. 10.1530/EJE-19-0696
Chatterjee S, Cottrell E, Rose SJ, Mushtaq T, Maharaj AV, Williams J, Savage MO, Metherell LA and Storr HL (2020). GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients. Endocrine Connections  vol. 9, (3) 211-222. 10.1530/EC-20-0026

2019

Novoselova TV, King PJ, Guasti L, Metherell LA, Clark AJL and Chan LF (2019). ACTH signalling and adrenal development: Lessons from mouse models. Endocrine Connections  vol. 8, (7) R122-R130. 10.1530/EC-19-0190
Maharaj A, Maudhoo A, Chan LF, Novoselova T, Prasad R, Metherell LA and Guasti L (2019). Isolated glucocorticoid deficiency: Genetic causes and animal models. Journal of Steroid Biochemistry and Molecular Biology  vol. 189, 73-80. 10.1016/j.jsbmb.2019.02.012
Storr HL, Chatterjee S, Metherell LA, Foley C, Rosenfeld RG, Backeljauw PF, Dauber A, Savage MO and Hwa V (2019). Nonclassical GH insensitivity: Characterization of mild abnormalities of GH action. Endocrine Reviews  vol. 40, (2) 476-505. 10.1210/er.2018-00146
Settas N, Persky R, Faucz FR, Sheanon N, Voutetakis A, Lodish M, Metherell LA and Stratakis CA (2019). SGPL1 deficiency: A rare cause of primary adrenal insufficiency. Journal of Clinical Endocrinology and Metabolism  vol. 104, (5) 1484-1490. 10.1210/jc.2018-02238
Maharaj A, Buonocore F, Meimaridou E, Ruiz-Babot G, Guasti L, Peng HM, Capper CP, Burgos-Tirado N, Prasad R, Hughes CR, Maudhoo A, Crowne E, Cheetham TD, Brain CE, Suntharalingham JP, Striglioni N, Yuksel B, Gurbuz F, Gupta S, Lindsay R, Couch R, Spoudeas HA, Guran T, Johnson S, Fowler DJ, Conwell LS, McInerney-Leo AM, Drui D, Cariou B and Lopez-Siguero JP (2019). Predicted benign and synonymous variants in CYP11A1 cause primary adrenal insufficiency through missplicing. Journal of The Endocrine Society  vol. 3, (1) 201-221. 10.1210/js.2018-00130

2018

Klammt J, Neumann D, Gevers EF, Andrew SF, Schwartz ID, Rockstroh D, Colombo R, Sanchez MA, Vokurkova D, Kowalczyk J, Metherell LA, Rosenfeld RG, Pfäffle R, Dattani MT, Dauber A and Hwa V (2018). Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation. Nature Communications  vol. 9, (1) 10.1038/s41467-018-04521-0
Novoselova TV, Hussain M, King PJ, Guasti L, Metherell LA, Charalambous M, Clark AJL and Chan LF (2018). MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. Faseb Journal  vol. 32, (11) 6186-6196. 10.1096/fj.201701274RR
Howard SR, Oleari R, Poliandri A, Chantzara V, Fantin A, Ruiz-Babot G, Metherell LA, Cabrera CP, Barnes MR, Wehkalampi K, Guasti L, Ruhrberg C, Cariboni A and Dunkel L (2018). HS6ST1 Insufficiency Causes Self-Limited Delayed Puberty in Contrast with Other GnRH Deficiency Genes. Journal of Clinical Endocrinology and Metabolism  vol. 103, (9) 3420-3429. 10.1210/jc.2018-00646
Chortis V, Taylor AE, Doig CL, Walsh MD, Meimaridou E, Jenkinson C, Rodriguez-Blanco G, Ronchi CL, Jafri A, Metherell LA, Hebenstreit D, Dunn WB, Arlt W and Foster PA (2018). Nicotinamide nucleotide transhydrogenase as a novel treatment target in adrenocortical carcinoma. Endocrinology  vol. 159, (8) 2836-2849. 10.1210/en.2018-00014
Chatterjee S, Shapiro L, Rose SJ, Mushtaq T, Clayton PE, Ten SB, Bhangoo A, Kumbattae U, Dias R, Savage MO, Metherell LA and Storr HL (2018). Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation. European Journal of Endocrinology  vol. 178, (5) 481-489. 10.1530/EJE-18-0042
Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF, Schubert U, Ziegler CG, Storr HL, Druce MR, Gevers EF, Drake WM, Srirangalingam U, Conway GS, King PJ, Metherell LA, Bornstein SR and Guasti L (2018). Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells. Cell Reports  vol. 22, (5) 1236-1249. 10.1016/j.celrep.2018.01.003
Meimaridou E, Goldsworthy M, Chortis V, Fragouli E, Foster PA, Arlt W, Cox R and Metherell LA (2018). NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice. Journal of Endocrinology  vol. 236, (1) 13-28. 10.1530/JOE-16-0638

2017

Shapiro L, Chatterjee S, Ramadan DG, Davies KM, Savage MO, Metherell LA and Storr HL (2017). Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity. European Journal of Endocrinology  vol. 177, (6) 485-501. 10.1530/EJE-17-0453
Salvatori R, Radian S, Diekmann Y, Iacovazzo D, David A, Gabrovska P, Grassi G, Bussell A-M, Stals K, Weber A, Quinton R, Crowne EC, Corazzini V, Metherell L, Kearney T, Du Plessis D, Sinha AK, Baborie A, Lecoq A-L, Chanson P, Ansorge O, Ellard S, Trainer PJ, Balding D, Thomas MG and Korbonits M (2017). In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism. Eur J Endocrinol  vol. 177, (3) 257-266. 10.1530/EJE-17-0293
Wacharasindhu S, Panamonta O, Shapiro L, Metherell LA, Savage MO and Storr HL (2017). Young Thai sisters with growth hormone insensitivity or Laron syndrome. Asian Biomedicine  vol. 11, (2) 167-170. 10.5372/1905-7415.1102.549
Vairamani K, Merjaneh L, Casano-Sancho P, Sanli ME, David A, Metherell LA, Savage MO, Del Pozo JS, Backeljauw PF, Rosenfeld RG, Aisenberg J, Dauber A and Hwa V (2017). Novel Dominant-Negative GH Receptor Mutations Expands the Spectrum of GHI and IGF-I Deficiency. Oxford University Press  J Endocr Soc  vol. 1, (4) 345-358. 10.1210/js.2016-1119
METHERELL LA, Prasad R, Storr HL, Guasti L, Maharaj A, Meimaridou E and Hadjidemetriou I (2017). Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. American Society For Clinical Investigation  Journal of Clinical Investigation  10.1172/JCI90171

2016

Metherell LA, Guerra-Assunção JA, Sternberg MJ and David A (2016). Three-Dimensional Model of Human Nicotinamide Nucleotide Transhydrogenase (NNT) and Sequence-Structure Analysis of its Disease-Causing Variations. Human Mutation  vol. 37, (10) 1074-1084. 10.1002/humu.23046
HOWARD SR, Guasti L, Ruiz-Babot G, Mancini A, David A, Storr H, Metherell LA, Sternberg MJE, Cabrera CP, Warren H, Barnes M, Quinton R, de Roux N, Young J, Guiochon-Mantel A, Wehkalampi K, Andre V, Gothilf Y, Cariboni A and Dunkel L (2016). IGSF10 mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty. Wiley  Embo Molecular Medicine  vol. 8, (6) 626-42. 10.15252/emmm.201606250
Tsai SL, Green J, Metherell LA, Curtis F, Fernandez B, Healey A and Curtis J (2016). Primary adrenocortical insufficiency case series: Genetic etiologies more common than expected. Hormone Research in Paediatrics  vol. 85, (1) 35-42. 10.1159/000441843

2015

Storr HL, Prasad R, Temple IK, Metherell LA, Savage MO and Walker JM (2015). Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency. J Endocrinol Invest  vol. 38, (4) 407-412. 10.1007/s40618-014-0195-1
Storr HL, Dunkel L, Kowalczyk J, Savage MO and Metherell LA (2015). Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation. Eur J Endocrinol  vol. 172, (2) 151-161. 10.1530/EJE-14-0541
Novoselova TV, Rath SR, Carpenter K, Pachter N, Dickinson JE, Price G, Chan LF, Choong CS and Metherell LA (2015). NNT Pseudoexon Activation as a Novel Mechanism for Disease in Two Siblings With Familial Glucocorticoid Deficiency. Endocrine Society  Journal of Clinical Endocrinology & Metabolism  vol. 100, (2) E350-E354. 10.1210/jc.2014-3641
Chan LF, Campbell DC, Novoselova TV, Clark AJL and Metherell LA (2015). Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children. Front Endocrinol (Lausanne)  vol. 6, 10.3389/fendo.2015.00113

2014

Prasad R, Chan LF, Hughes CR, Kaski JP, Kowalczyk JC, Savage MO, Peters CJ, Nathwani N, Clark AJL, Storr HL and Metherell LA (2014). Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab  vol. 99, (8) E1556-E1563. 10.1210/jc.2013-3844
Prasad R, Kowalczyk JC, Meimaridou E, Storr HL and Metherell LA (2014). Oxidative stress and adrenocortical insufficiency. J Endocrinol  vol. 221, (3) R63-R73. 10.1530/JOE-13-0346
Högler W, Martin DD, Crabtree N, Nightingale P, Tomlinson J, Metherell L, Rosenfeld R, Hwa V, Rose S, Walker J, Shaw N, Barrett T and Frystyk J (2014). IGFALS gene dosage effects on serum IGF-I and glucose metabolism, body composition, bone growth in length and width, and the pharmacokinetics of recombinant human IGF-I administration. J Clin Endocrinol Metab  vol. 99, (4) E703-E712. 10.1210/jc.2013-3718
Poukoulidou T, Kowalczyk J, Metherell L, De Schepper J and Maes M (2014). A Novel Homozygous Mutation of the IGFALS Gene in a Female Adolescent: Indirect Evidence for a Contributing Role of the Circulating IGF-I Pool in the Pubertal Growth Spurt. Hormone Research in Paediatrics  vol. 81, (6) 422-427. 10.1159/000358329

2013

Habeb AM, Hughes CR, Al-Arabi R, Al-Muhamadi A, Clark AJL and Metherell LA (2013). Familial glucocorticoid deficiency: a diagnostic challenge during acute illness. European Journal of Pediatrics  vol. 172, (10) 1407-1410. 10.1007/s00431-013-2044-1
Prasad R, Metherell LA, Clark AJ and Storr HL (2013). Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology  vol. 154, (9) 3209-3218. 10.1210/en.2013-1241
Meimaridou E, Prasad R, Kowalczyk JC, Clark AJL, Storr HL and Metherell LA (2013). Genome sequencing reveals mitochondrial thiol systems are essential for antioxidant defence in human adrenal glands. Free Radical Biology and Medicine  vol. 65, S38-S38. 10.1016/j.freeradbiomed.2013.08.052
Meimaridou E, Hughes CR, Kowalczyk J, Guasti L, Chapple JP, King PJ, Chan LF, Clark AJL and Metherell LA (2013). Familial glucocorticoid deficiency: New genes and mechanisms. Mol Cell Endocrinol  vol. 371, (1-2) 195-200. 10.1016/j.mce.2012.12.010
Meimaridou E, Hughes CR, Kowalczyk J, Guasti L, Chapple JP, King PJ, Chan LF, Clark AJL and Metherell LA (2013). Familial glucocorticoid deficiency: New genes and mechanisms. Molecular and Cellular Endocrinology  vol. 371, (1-2) 195-200. 10.1016/j.mce.2012.12.010
Meimaridou E, Hughes CR, Kowalczyk J, Chan LF, Clark AJL and Metherell LA (2013). ACTH resistance: genes and mechanisms. Endocr Dev  vol. 24, 57-66. 10.1159/000342504
Yates R, Katugampola H, Cavlan D, Cogger K, Meimaridou E, Hughes C, Metherell L, Guasti L and King P (2013). Adrenocortical development, maintenance, and disease. Curr Top Dev Biol  vol. 106, 239-312. 10.1016/B978-0-12-416021-7.00007-9

2012

Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, Frommolt P, Nürnberg P, Mann NP, Banerjee R, Saka HN, Chapple JP, King PJ, Clark AJL and Metherell LA (2012). Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet  vol. 44, (7) 740-742. 10.1038/ng.2299
Turan S, Hughes C, Atay Z, Guran T, Haliloglu B, Clark AJL, Bereket A and Metherell LA (2012). An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W). J Clin Endocrinol Metab  vol. 97, (5) E771-E774. 10.1210/jc.2011-2414
Hughes CR, Guasti L, Meimaridou E, Chuang C-H, Schimenti JC, King PJ, Costigan C, Clark AJL and Metherell LA (2012). MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. Journal of Clinical Investigation  vol. 122, (3) 814-820. 10.1172/JCI60224

2011

Jain V, Metherell LA, David A, Sharma R, Sharma PK, Clark AJL and Chan LF (2011). Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein. Eur J Endocrinol  vol. 165, (6) 987-991. 10.1530/EJE-11-0581
McEachern R, Drouin J, Metherell L, Huot C, Van Vliet G and Deal C (2011). Severe cortisol deficiency associated with reversible growth hormone deficiency in two infants: what is the link? J Clin Endocrinol Metab  vol. 96, (9) 2670-2674. 10.1210/jc.2011-0129
David A, Hwa V, Metherell LA, Netchine I, Camacho-Hübner C, Clark AJL, Rosenfeld RG and Savage MO (2011). Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr Rev  vol. 32, (4) 472-497. 10.1210/er.2010-0023
Chan LF, Metherell LA and Clark AJL (2011). Effects of melanocortins on adrenal gland physiology. Eur J Pharmacol  vol. 660, (1) 171-180. 10.1016/j.ejphar.2010.11.041
Savage MO, Hwa V, David A, Rosenfeld RG and Metherell LA (2011). Genetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth. Front Endocrinol (Lausanne)  vol. 2, 10.3389/fendo.2011.00095

2010

Hughes CR, Chung TT, Habeb AM, Kelestimur F, Clark AJL and Metherell LA (2010). Missense mutations in the melanocortin 2 receptor accessory protein that lead to late onset familial glucocorticoid deficiency type 2. J Clin Endocrinol Metab  vol. 95, (7) 3497-3501. 10.1210/jc.2009-2731
David A, Srirangalingam U, Metherell LA, Khoo B and Clark AJL (2010). Repair of aberrant splicing in growth hormone receptor by antisense oligonucleotides targeting the splice sites of a pseudoexon. J Clin Endocrinol Metab  vol. 95, (7) 3542-3546. 10.1210/jc.2009-1968
Moyes VJ, Walker DM, Owusu-Antwi S, Maher KT, Metherell L, Akker SA, Monson JP, Clark AJL and Drake WM (2010). d3-GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults. Clin Endocrinol (Oxf)  vol. 72, (6) 807-813. 10.1111/j.1365-2265.2009.03768.x
Hughes C, Chung TT, Clark AJ and Metherell L (2010). FUNCTIONAL CHARACTERISATION OF A MISSENSE MUTATION OF MRAP LEADING TO FAMILIAL GLUCOCORTICOID DEFICIENCY. Irish J Med Sci  vol. 179, S263-S263.
Chung T-TLL, Chan LF, Metherell LA and Clark AJL (2010). Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol (Oxf)  vol. 72, (5) 589-594. 10.1111/j.1365-2265.2009.03663.x
Dias RP, Chan LF, Metherell LA, Pearce SHS and Clark AJL (2010). Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency. Eur J Endocrinol  vol. 162, (2) 357-359. 10.1530/EJE-09-0720
David A, Miraki-Moud F, Shaw NJ, Savage MO, Clark AJL and Metherell LA (2010). Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity. Eur J Endocrinol  vol. 162, (1) 37-42. 10.1530/EJE-09-0583
David A, Rose SJ, Miraki-Moud F, Metherell LA, Savage MO, Clark AJL and Camacho-Hübner C (2010). Acid-labile subunit deficiency and growth failure: description of two novel cases. Horm Res Paediatr  vol. 73, (5) 328-334. 10.1159/000308164
Storr HL, Metherell LA, Dias R, Savage MO, Rasmussen AK, Clark AJL and Main KM (2010). Familial Isolated Primary Pigmented Nodular Adrenocortical Disease Associated with a Novel Low Penetrance PRKAR1A Gene Splice Site Mutation. Horm Res Paediat  vol. 73, (2) 115-119. 10.1159/000277629
Storr HL, Metherell LA, Dias R, Savage MO, Rasmussen AK, Clark AJL and Main KM (2010). Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation. Horm Res Paediatr  vol. 73, (2) 115-119. 10.1159/000277629

2009

Metherell LA, Naville D, Halaby G, Begeot M, Huebner A, Nürnberg G, Nürnberg P, Green J, Tomlinson JW, Krone NP, Lin L, Racine M, Berney DM, Achermann JC, Arlt W and Clark AJL (2009). Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab  vol. 94, (10) 3865-3871. 10.1210/jc.2009-0467
(2009). Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long-term mineralocorticoid deficiency. Clin Endocrinol (Oxf)  vol. 71, (2) 171-175. 10.1111/j.1365-2265.2008.03511.x
Milward A, Metherell L, Maamra M, Barahona MJ, Wilkinson IR, Camacho-Hübner C, Savage MO, Bidlingmaier CM, Clark AJL, Ross RJM and Webb SM (2009). Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after box1, resulting in isolated failure of STAT 5 signal transduction (Journal of Clinical Endocrinology and Metabolism (2004) 89 (1259-1266)). Journal of Clinical Endocrinology and Metabolism  vol. 94, (7)
Milward A, Metherell L, Maamra M, Barahona MJ, Wilkinson IR, Camacho-Huebner C, Savage MO, Bidlingmaier CM, Clark AJL, Ross RJM and Webb SM (2009). Growth Hormone (GH) Insensitivity Syndrome due to a GH Receptor Truncated after Box1, Resulting in Isolated Failure of STAT 5 Signal Transduction (vol 89, pg 1259, 2004). Journal of Clinical Endocrinology & Metabolism  vol. 94, (7) 2674-2674.
Chan LF, Webb TR, Chung T-T, Meimaridou E, Cooray SN, Guasti L, Chapple JP, Egertová M, Elphick MR, Cheetham ME, Metherell LA and Clark AJL (2009). MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc Natl Acad Sci U S A  vol. 106, (15) 6146-6151. 10.1073/pnas.0809918106
Chan LF, Chung T-T, Massoud AF, Metherell LA and Clark AJL (2009). Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations. Eur J Endocrinol  vol. 160, (4) 705-710. 10.1530/EJE-08-0636
Clark AJL, Chan LF, Chung T-T and Metherell LA (2009). The genetics of familial glucocorticoid deficiency. Best Pract Res Clin Endocrinol Metab  vol. 23, (2) 159-165. 10.1016/j.beem.2008.09.006
Cooray SN, Chan L, Webb TR, Metherell L and Clark AJL (2009). Accessory proteins are vital for the functional expression of certain G protein-coupled receptors. Mol Cell Endocrinol  vol. 300, (1-2) 17-24. 10.1016/j.mce.2008.10.004
Savage MO, David A, Camacho-Hubner C, Metherell LA and Clark AJL (2009). Phenotypic aspects of growth hormone- and IGF-I-resistant syndromes. Endocr Dev  vol. 14, 143-150. 10.1159/000207483
Metherell LA, Chung TT, Chan LF and Clark AJL (2009). Genotype:phenotype relationships in familial glucocorticoid deficiency types 1 and 2. Horm Res  vol. 72, 211-211.
Chan LF, David A, Jain V, Clark AJL and Metherell LA (2009). A novel splice mutation (IVSds3+3insTA) in the melanocortin 2 receptor accessory protein that leads to skipping of exon 3. Horm Res  vol. 72, 70-70.
Hughes CR, Chung TT, Habeb AM, Clark AJ and Metherell LA (2009). Functional characterisation of a missense mutation (p.Y59D) of MRAP which leads to familial glucocorticoid deficiency type 2. Horm Res  vol. 72, 42-42.

2008

Chung TT, Webb TR, Chan LF, Cooray SN, Metherell LA, King PJ, Chapple JP and Clark AJL (2008). The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface. J Clin Endocrinol Metab  vol. 93, (12) 4948-4954. 10.1210/jc.2008-1744
Chan LF, Clark AJL and Metherell LA (2008). Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action. Horm Res  vol. 69, (2) 75-82. 10.1159/000111810
Cooray SN, Chan L, Metherell L, Storr H and Clark AJL (2008). Adrenocorticotropin resistance syndromes. Endocr Dev  vol. 13, 99-116. 10.1159/000134828
David A, Rose S, Miraki-Moud F, Metherell L, Clark A, Savage M and Camacho-Hubner C (2008). Acid-labile subunit gene mutations: Clinical, biochemical and molecular study in two unrelated families. Horm Res  vol. 70, 31-31.
Chan L, Chung TT, Massoud A, Metherell L and Clark A (2008). Functional consequence of two opposing MC2R mutations in a child with severe FGD phenotype. Horm Res  vol. 70, 23-23.

2007

Vallette-Kasic S, Couture C, Balsalobre A, Gauthier Y, Metherell L, Dattani M and Drouin J (2007). The TPIT gene mutation M86R associated with isolated adrenocorticotropin deficiency interferes with protein: Protein interactions. J Clin Endocr Metab  vol. 92, (10) 3991-3999. 10.1210/jc.2007-0284
Rumié H, Metherell LA, Clark AJL, Beauloye V and Maes M (2007). Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein. Eur J Endocrinol  vol. 157, (4) 539-542. 10.1530/EJE-07-0242
Savage MO, Camacho-Hübner C, David A, Metherell LA, Hwa V, Rosenfeld RG and Clark AJL (2007). Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy? Eur J Endocrinol  vol. 157 Suppl 1, S33-S37. 10.1530/EJE-07-0292
Keegan CE, Hutz JE, Krause AS, Koehler K, Metherell LA, Boikos S, Stergiopoulos S, Clark AJL, Stratakis CA, Huebner A and Hammer GD (2007). Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes. Clin Endocrinol  vol. 67, (2) 168-174. 10.1111/j.1365-2265.2007.02855.x
David A, Camacho-Hübner C, Bhangoo A, Rose SJ, Miraki-Moud F, Akker SA, Butler GE, Ten S, Clayton PE, Clark AJL, Savage MO and Metherell LA (2007). An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes. J Clin Endocrinol Metab  vol. 92, (2) 655-659. 10.1210/jc.2006-1527
Lin L, Hindmarsh PC, Metherell LA, Alzyoud M, Al-Ali M, Brain CE, Clark AJL, Dattani MT and Achermann JC (2007). Severe loss-of-function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt-losing adrenal hypoplasia. Clin Endocrinol (Oxf)  vol. 66, (2) 205-210. 10.1111/j.1365-2265.2006.02709.x
Hwa V, Camacho-Hübner C, Little BM, David A, Metherell LA, El-Khatib N, Savage MO and Rosenfeld RG (2007). Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene. Horm Res  vol. 68, (5) 218-224. 10.1159/000101334

2006

Metherell LA, Chan LF and Clark AJL (2006). The genetics of ACTH resistance syndromes. Best Pract Res Clin Endocrinol Metab  vol. 20, (4) 547-560. 10.1016/j.beem.2006.09.002
Savage MO, Attie KM, David A, Metherell LA, Clark AJL and Camacho-Hübner C (2006). Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nat Clin Pract Endocrinol Metab  vol. 2, (7) 395-407. 10.1038/ncpendmet0195
Clark AJL and Metherell LA (2006). Mechanisms of disease: the adrenocorticotropin receptor and disease. Nat Clin Pract Endocrinol Metab  vol. 2, (5) 282-290. 10.1038/ncpendmet0165
Maamra M, Milward A, Esfahani HZ, Abbott LP, Metherell LA, Savage MO, Clark AJL and Ross RJM (2006). A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling. J Endocrinol  vol. 188, (2) 251-261. 10.1677/joe.1.06252

2005

Clark AJL, Metherell LA, Cheetham ME and Huebner A (2005). Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab  vol. 16, (10) 451-457. 10.1016/j.tem.2005.10.006
David A, Metherell LA, Clark AJL, Camacho-Hubner C and Savage MO (2005). Diagnostic and therapeutic advances in growth hormone insensitivity. Endocrin Metab Clin  vol. 34, (3) 581-+. 10.1016/j.ecl.2005.04.009
Hui HNT, Metherell LA, Ng KL, Savage MO, Camacho-Hubner C and Clark AJL (2005). Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome. J Pediatr Endocr Met  vol. 18, (2) 209-213. 10.1515/jpem.2005.18.2.209
Metherell LA, Chapple JP, Cooray S, David A, Becker C, Rüschendorf F, Naville D, Begeot M, Khoo B, Nürnberg P, Huebner A, Cheetham ME and Clark AJL (2005). Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet  vol. 37, (2) 166-170. 10.1038/ng1501
CLARK AJL, Metherell LA, Huebner A, Begeot M and Naville D (2005). Genetics of ACTH insensitivity syndromes. Annals of Endocrinology  vol. 66, 247-249. 10.1016/S0003-4266(05)81757-3

2004

Metherell LA, Savage MO, Dattani M, Walker J, Clayton PE, Farooqi IS and Clark AJL (2004). TPIT mutations are associated with early-onset, but not late-onset isolated ACTH deficiency. Eur J Endocrinol  vol. 151, (4) 463-465. 10.1530/eje.0.1510463
Milward A, Metherell L, Maamra M, Barahona MJ, Wilkinson IR, Camacho-Hubner C, Savage MO, Bidlingmaier CM, Clark AJL, Ross RJM and Webb SM (2004). Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after box1, resulting in isolated failure of STAT 5 signal transduction. J Clin Endocr Metab  vol. 89, (3) 1259-1266. 10.1210/jc.2003-031418

2003

Kola B, Korbonits M, Diaz-Cano S, Kaltsas G, Morris DG, Jordan S, Metherell L, Powell M, Czirják S, Arnaldi G, Bustin S, Boscaro M, Mantero F and Grossman AB (2003). Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. Clin Endocrinol (Oxf)  vol. 59, (3) 328-338. 10.1046/j.1365-2265.2003.01851.x

2002

Bjarnason R, Banerjee K, Rose SJ, Rosberg S, Metherell L, Clark AJL, Albertsson-Wikland K and Savage MO (2002). Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity. Clin Endocrinol  vol. 57, (3) 357-361. 10.1046/j.1365-2265.2002.01607.x

2001

Metherell LA, Akker SA, Munroe PB, Rose SJ, Caulfield M, Savage MO, Chew SL and Clark AJ (2001). Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity. Am J Hum Genet  vol. 69, (3) 641-646. 10.1086/323266
Edwards KJ, Metherell LA, Yates M and Saunders NA (2001). Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol  vol. 39, (9) 3350-3352. 10.1128/jcm.39.9.3350-3352.2001
Clark AJ, Metherell L, Swords FM and Elias LL (2001). The molecular pathogenesis of ACTH insensitivity syndromes. Ann Endocrinol (Paris)  vol. 62, (2) 207-211.
Clark AJ, Metherell L, Swords FM and Elias LL (2001). The molecular pathogenesis of ACTH insensitivity syndromes. Annales D'Endocrinologie  vol. 62, (2) 207-211.

2000

Elias LLK, Huebner A, Metherell LA, Canas A, Warne GL, Manca Bitti ML, Cianfarani S, Clayton PE, Savage MO and Clark AJL (2000). Tall stature in familial glucocorticoid deficiency. Clinical Endocrinology  vol. 53, (4) 423-430. 10.1046/j.1365-2265.2000.01122.x

1999

Metherell LA, Logan JMJ and Stanley J (1999). PCR-enzyme-linked immunosorbent assay for detection and identification of Campylobacter species: Application to isolates and stool samples. Journal of Clinical Microbiology  vol. 37, (2) 433-435. 10.1128/JCM.37.2.433-435.1999
Arnold C, Metherell L, Clewley JP and Stanley J (1999). Predictive modelling of fluorescent AFLP: A new approach to the molecular epidemiology of E. coli. Research in Microbiology  vol. 150, (1) 33-44. 10.1016/S0923-2508(99)80044-8
Clode FE, Metherell LA, Pitt TL, Wilsher ML, Kolbe J, Morris AJ, Welch DF and Vandamme PAR (1999). Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis (multiple letters). American Journal of Respiratory and Critical Care Medicine  vol. 160, (1) 374-375. 10.1164/ajrccm.160.1.16011
Arnold C, Metherell L, Willshaw G, Maggs A and Stanley J (1999). Predictive fluorescent amplified-fragment length polymorphism analysis of Escherichia coli: High-resolution typing method with phylogenetic significance. Journal of Clinical Microbiology  vol. 37, (5) 1274-1279. 10.1128/jcm.37.5.1274-1279.1999

1997

Metherell LA, Hurst C and Bruce IJ (1997). Rapid, sensitive, microbial detection by gene amplification using restriction endonuclease target sequences. Molecular and Cellular Probes  vol. 11, (4) 297-308. 10.1006/mcpr.1997.0120
Saunders NA, Metherell L and Patel S (1997). Investigation of an outbreak of multidrug resistant tuberculosis among renal patients using rpo B gene sequencing and IS6110 inverse PCR. Journal of Infection  vol. 35, (2) 129-133. 10.1016/S0163-4453(97)91512-7
Saunders NA, Hallas G, Gaworzewska ET, Metherell L, Efstratiou A, Hookey JV and George RC (1997). PCR-enzyme-linked immunosorbent assay and sequencing as an alternative to serology for M-antigen typing of Streptococcus pyogenes. Journal of Clinical Microbiology  vol. 35, (10) 2689-2691. 10.1128/jcm.35.10.2689-2691.1997

Grants

Grants of specific relevance to Predictive in vitro Models
Improved genetic diagnosis of primary adrenal insufficiency
Storr HL, Metherell LA and Chan L
£500,199 Barts Charity (01-08-2018 - 31-07-2022)
Investigating the role of the sphingolipid pathway in a novel syndromic form of primary adrenal insufficiency
Metherell LA
£318,860 Barts Charity (01-04-2020 - 01-01-2020)


Antioxidant defence in adrenocortical cells
Metherell LA
£392,467 Medical Research Council (31-03-2013 - 30-03-2016)
Abstract